Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leramistat repair effects in rheumatoid arthritis
ISRCTN16456769Phase 2Recruiting
- Sponsor
- Istesso
- Start
- Apr 2026
- Modality
- Small Molecules
01
Overview
Phase 2 trial of Leramistat in rheumatoid arthritis (RA), sponsored by Istesso. Primary endpoint: Primary endpoint not yet disclosed. Started Apr 2026; status: recruiting.
02
Drugs
Leramistat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN16456769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16456769.